Ten post jest także dostępny w języku: polski
Tomma Diagnostyka Obrazowa invests in the diagnostic imaging market. It acquired Bonus Diagnosta, a company that runs two magnetic resonance imaging laboratories in Bydgoszcz.
Tomma Diagnostyka Obrazowa enters a new market
With the acquisition of 100% of shares in Bonus Diagnosta, Tomma Diagnostyka Obrazowa entered Bydgoszcz. The company did not run a labotratory in this city before. The magnetic resonance imaging labs Bonus Diagnosta are located in the Hospital of St. Luke (Szpital sw. Lukasza) and in the Gizinski Medical Centre (Centrum Medyczny Gizinscy).
That’s Tomma’s 26th location, considering the cities. The company is still looking for acquisition targets and plans to open new establishments under the Tomma brand in the near future. Recently, Tomma has opened magnetic resonance laboratories in Bialystok (January 2019), Gdynia (December 2018) and Opole (November 2018).
Diagnostic imaging – very promising
Tar Heel Capital, the private equity fund to which Tomma belongs, considers the imaging diagnostics segment to be one of the most promising in Poland. This is due to the low saturation of diagnostic equipment in comparison to other OECD countries. This is confirmed by PMR data. Our report shows that in 2018-2023 the segment of imaging diagnostics services in Poland will grow at an average annual rate of 5.7% (CAGR). It should be remembered that the segment of imaging diagnostics, especially those cost-intensive ones, is highly dependent on the financing of the National Health Fund. Therefore, the development factor is certainly the abolition of the limits for computed tomography and magnetic resonance examinations, which took place in April 2019.
Since Tar Heel Capital takeover in 2014, Tomma’s revenue has been growing at a rate of 40.5% annually (CAGR). In 2018, the company performed computer tomography, magnetic resonance, ultrasound and X-ray examinations on nearly 200,000 patients.